Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study-Reference-Cited by-同舟云学术

Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study

Published:2016-01 Issue:1 Volume:214 Page:108.e1-108.e14
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Kim Mimi Y.,Buyon Jill P.,Guerra Marta M.,Rana Sarosh,Zhang Dongsheng,Laskin Carl A.,Petri Michelle,Lockshin Michael D.,Sammaritano Lisa R.,Branch D. Ware,Porter T. Flint,Merrill Joan T.,Stephenson Mary D.,Gao Qi,Karumanchi S. Ananth,Salmon Jane E.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference44 articles.

1. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort;Petri;J Rheumatol,1993

2. Outcome of lupus pregnancy: a controlled study;Georgiou;Rheumatology (Oxford),2000

3. A national study of the complications of lupus in pregnancy;Clowse;Am J Obstet Gynecol,2008

4. Predictors of pregnancy outcome in a prospective, multiethnic cohort of lupus patients: a cohort study;Buyon;Ann Intern Med,2015

5. The uterine spiral arteries in human pregnancy: facts and controversies;Pijnenborg;Placenta,2006

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pregnancy and reproductive health issues in systemic lupus erythematosus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Pregnancy outcome predictors in systemic lupus erythematosus: prospective for brighter perspectives;The Lancet Rheumatology;2024-08

3. Risk Assessment and Optimization for Pregnancy in Patients with Rheumatic Diseases;Diagnostics;2024-07-02

4. Significance of the sFlt-1/PlGF Ratio in Certain Cohorts – What Needs to be Considered?;Geburtshilfe und Frauenheilkunde;2024-07

5. Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy;American Journal of Obstetrics and Gynecology;2024-07